Review



antibodies for znt4 ba3484  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Boster Bio antibodies for znt4 ba3484
    Antibodies For Znt4 Ba3484, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies for znt4 ba3484/product/Boster Bio
    Average 93 stars, based on 3 article reviews
    antibodies for znt4 ba3484 - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    92
    Bioss pept1 polyclonal antibody
    Pept1 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pept1 polyclonal antibody/product/Bioss
    Average 92 stars, based on 1 article reviews
    pept1 polyclonal antibody - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology pept1
    Pept1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pept1/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    pept1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Human Protein Atlas pept1 transporter
    Pept1 Transporter, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pept1 transporter/product/Human Protein Atlas
    Average 90 stars, based on 1 article reviews
    pept1 transporter - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher pept1 transporter
    Pept1 Transporter, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pept1 transporter/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    pept1 transporter - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Boster Bio antibodies for znt4 ba3484
    Antibodies For Znt4 Ba3484, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies for znt4 ba3484/product/Boster Bio
    Average 93 stars, based on 1 article reviews
    antibodies for znt4 ba3484 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Boster Bio pept1
    Pept1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pept1/product/Boster Bio
    Average 93 stars, based on 1 article reviews
    pept1 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Huabio Inc anti-pept1 #ha500444
    Anti Pept1 #Ha500444, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-pept1 #ha500444/product/Huabio Inc
    Average 90 stars, based on 1 article reviews
    anti-pept1 #ha500444 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Huabio Inc anti-pept1
    Anti Pept1, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-pept1/product/Huabio Inc
    Average 90 stars, based on 1 article reviews
    anti-pept1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Huabio Inc pept1 antibody
    <t>PEPT1</t> was upregulated in HCC and predicted poor clinical outcome. A) The protein expression levels of PEPT1 in normal hepatocytes and several HCC cell lines were detected by Western blot. B,C) <t>PEPT1</t> <t>protein</t> levels in fresh HCC and adjacent nontumor tissues detection by Western blot ( n = 12). D) Representative IHC images of PEPT1 in HCC tissue ( n = 90) and corresponding normal tissue ( n = 90). Scale bar, 200 µm. E) The corresponding IHC scores (H score) was compared on the right. F) Proportion of different expression levels of PEPT1 in HCC patients at different stages. G,H) Kaplan–Meier analysis of overall survival (OS) or disease‐free survival (DFS) curves after having assigned HCC patients to high/low of PEPT1 expression subgroups. I,J) Kaplan–Meier analysis of overall survival (OS) data from GSE20140 (I) and ICJC (LIRI‐JP) liver cancer database. * P < 0.05, ** P < 0.01, and *** P < 0.001.
    Pept1 Antibody, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pept1 antibody/product/Huabio Inc
    Average 90 stars, based on 1 article reviews
    pept1 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    PEPT1 was upregulated in HCC and predicted poor clinical outcome. A) The protein expression levels of PEPT1 in normal hepatocytes and several HCC cell lines were detected by Western blot. B,C) PEPT1 protein levels in fresh HCC and adjacent nontumor tissues detection by Western blot ( n = 12). D) Representative IHC images of PEPT1 in HCC tissue ( n = 90) and corresponding normal tissue ( n = 90). Scale bar, 200 µm. E) The corresponding IHC scores (H score) was compared on the right. F) Proportion of different expression levels of PEPT1 in HCC patients at different stages. G,H) Kaplan–Meier analysis of overall survival (OS) or disease‐free survival (DFS) curves after having assigned HCC patients to high/low of PEPT1 expression subgroups. I,J) Kaplan–Meier analysis of overall survival (OS) data from GSE20140 (I) and ICJC (LIRI‐JP) liver cancer database. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Advanced Science

    Article Title: Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis

    doi: 10.1002/advs.202306671

    Figure Lengend Snippet: PEPT1 was upregulated in HCC and predicted poor clinical outcome. A) The protein expression levels of PEPT1 in normal hepatocytes and several HCC cell lines were detected by Western blot. B,C) PEPT1 protein levels in fresh HCC and adjacent nontumor tissues detection by Western blot ( n = 12). D) Representative IHC images of PEPT1 in HCC tissue ( n = 90) and corresponding normal tissue ( n = 90). Scale bar, 200 µm. E) The corresponding IHC scores (H score) was compared on the right. F) Proportion of different expression levels of PEPT1 in HCC patients at different stages. G,H) Kaplan–Meier analysis of overall survival (OS) or disease‐free survival (DFS) curves after having assigned HCC patients to high/low of PEPT1 expression subgroups. I,J) Kaplan–Meier analysis of overall survival (OS) data from GSE20140 (I) and ICJC (LIRI‐JP) liver cancer database. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: Membranes were blocked with 5% non‐fat milk (Bio‐Rad) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: PEPT1 (1:1000, Huabio, #HA500444), MAP4K4 (1:1000, Cusabio, #CSB‐PA013439LA01HU), G3BP2 (1:1000, Proteintech, #16276‐1‐AP), phospho‐Threonine (1:1000, CST, #9386), E‐cadherin (1:1000, Proteintech, #20874‐1‐AP), N‐cadherin (1:1000, Proteintech, #22018‐1‐AP), vimentin (1:2500, Proteintech, #10366‐1‐AP), β‐catenin (1:1000, Huabio, #HA500444), and β‐actin (1:10 000, Proteintech, #66009‐1‐Ig).

    Techniques: Expressing, Western Blot

    PEPT1 overexpression promoted HCC metastasis in vitro and in vivo. A) Bel7405 and HCCLM3 cells were infected with lentiviral particles expressing PEPT1 plasmid. The overexpression efficacy was detected by Western blot analysis. B) Representative images and quantification of the indicated cells in the wound‐healing migration assays. Scale bar, 100 µm. C,D) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. E,F) Representative images and quantification of the luciferase expression in pulmonary metastatic lesions. G,H) Representative images of HE and IHC staining of lungs resected from tail vein injection metastasis mouse model. Scale bar, 500 µm, 50 µm. The number of lung metastatic tumors in each group were determined. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Advanced Science

    Article Title: Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis

    doi: 10.1002/advs.202306671

    Figure Lengend Snippet: PEPT1 overexpression promoted HCC metastasis in vitro and in vivo. A) Bel7405 and HCCLM3 cells were infected with lentiviral particles expressing PEPT1 plasmid. The overexpression efficacy was detected by Western blot analysis. B) Representative images and quantification of the indicated cells in the wound‐healing migration assays. Scale bar, 100 µm. C,D) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. E,F) Representative images and quantification of the luciferase expression in pulmonary metastatic lesions. G,H) Representative images of HE and IHC staining of lungs resected from tail vein injection metastasis mouse model. Scale bar, 500 µm, 50 µm. The number of lung metastatic tumors in each group were determined. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: Membranes were blocked with 5% non‐fat milk (Bio‐Rad) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: PEPT1 (1:1000, Huabio, #HA500444), MAP4K4 (1:1000, Cusabio, #CSB‐PA013439LA01HU), G3BP2 (1:1000, Proteintech, #16276‐1‐AP), phospho‐Threonine (1:1000, CST, #9386), E‐cadherin (1:1000, Proteintech, #20874‐1‐AP), N‐cadherin (1:1000, Proteintech, #22018‐1‐AP), vimentin (1:2500, Proteintech, #10366‐1‐AP), β‐catenin (1:1000, Huabio, #HA500444), and β‐actin (1:10 000, Proteintech, #66009‐1‐Ig).

    Techniques: Over Expression, In Vitro, In Vivo, Infection, Expressing, Plasmid Preparation, Western Blot, Migration, Luciferase, Immunohistochemistry, Injection

    PEPT1 knockdown inhibited HCC metastasis in vitro and in vivo. A) Huh7 and PLC/PRF/5 cells were infected with lentiviral particles expressing shRNA targeting PEPT1. The knockdown efficacy was detected by Western blot analysis. B) Representative images and quantification of the indicated cells in the wound‐healing migration assays. Scale bar, 100 µm. C,D) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. E,F) Representative images and quantification of the luciferase expression in pulmonary metastatic lesions. G,H) Representative HE staining and IHC results of PEPT1 in lungs metastatic tumor resected from tail vein injection metastasis mouse model. Scale bar, 500 µm, 50 µm. The number of lung metastatic tumors in each group were determined. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Advanced Science

    Article Title: Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis

    doi: 10.1002/advs.202306671

    Figure Lengend Snippet: PEPT1 knockdown inhibited HCC metastasis in vitro and in vivo. A) Huh7 and PLC/PRF/5 cells were infected with lentiviral particles expressing shRNA targeting PEPT1. The knockdown efficacy was detected by Western blot analysis. B) Representative images and quantification of the indicated cells in the wound‐healing migration assays. Scale bar, 100 µm. C,D) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. E,F) Representative images and quantification of the luciferase expression in pulmonary metastatic lesions. G,H) Representative HE staining and IHC results of PEPT1 in lungs metastatic tumor resected from tail vein injection metastasis mouse model. Scale bar, 500 µm, 50 µm. The number of lung metastatic tumors in each group were determined. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: Membranes were blocked with 5% non‐fat milk (Bio‐Rad) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: PEPT1 (1:1000, Huabio, #HA500444), MAP4K4 (1:1000, Cusabio, #CSB‐PA013439LA01HU), G3BP2 (1:1000, Proteintech, #16276‐1‐AP), phospho‐Threonine (1:1000, CST, #9386), E‐cadherin (1:1000, Proteintech, #20874‐1‐AP), N‐cadherin (1:1000, Proteintech, #22018‐1‐AP), vimentin (1:2500, Proteintech, #10366‐1‐AP), β‐catenin (1:1000, Huabio, #HA500444), and β‐actin (1:10 000, Proteintech, #66009‐1‐Ig).

    Techniques: Knockdown, In Vitro, In Vivo, Infection, Expressing, shRNA, Western Blot, Migration, Luciferase, Staining, Injection

    PEPT1‐mediated HCC metastasis was dependent on MAP4K4. A) Protein expression of EMT‐associated proteins in HCC cells with PEPT1 overexpression or knockdown. B) Volcano plot of all differential genes in Huh7 cells that stably express shRNA stargeting PEPT1 or scramble control. C) Go analysis showed that differentially expressed genes were mainly enriched in protein kinase binding. D) The protein expression of MAP4K4 in PEPT1‐overexpression or PEPT1‐silencing HCC cells was detected by Western blot analysis. E) MAP4K4 protein levels in fresh HCC and adjacent nontumor tissues detection by Western blot ( n = 12). F) Representative IHC images of MAP4K4 in HCC tissue ( n = 10) and corresponding normal tissue ( n = 10). Scale bar, 100 µm. G) The correlation between PEPT1 and MAP4K4 was analyzed based on HCC date from the ICJC (LIRI‐JP) database (left) and Western blot results (right). H) Kaplan–Meier analysis of overall survival (OS) data from ICJC (LIRI‐JP) liver cancer database. I) Representative images and quantification of the indicated cells in the wound‐healing migration assays. Scale bar, 100 µm. J) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. K) Protein expression of EMT‐associated proteins in HCC cells with MAP4K4 knockdown. L) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Advanced Science

    Article Title: Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis

    doi: 10.1002/advs.202306671

    Figure Lengend Snippet: PEPT1‐mediated HCC metastasis was dependent on MAP4K4. A) Protein expression of EMT‐associated proteins in HCC cells with PEPT1 overexpression or knockdown. B) Volcano plot of all differential genes in Huh7 cells that stably express shRNA stargeting PEPT1 or scramble control. C) Go analysis showed that differentially expressed genes were mainly enriched in protein kinase binding. D) The protein expression of MAP4K4 in PEPT1‐overexpression or PEPT1‐silencing HCC cells was detected by Western blot analysis. E) MAP4K4 protein levels in fresh HCC and adjacent nontumor tissues detection by Western blot ( n = 12). F) Representative IHC images of MAP4K4 in HCC tissue ( n = 10) and corresponding normal tissue ( n = 10). Scale bar, 100 µm. G) The correlation between PEPT1 and MAP4K4 was analyzed based on HCC date from the ICJC (LIRI‐JP) database (left) and Western blot results (right). H) Kaplan–Meier analysis of overall survival (OS) data from ICJC (LIRI‐JP) liver cancer database. I) Representative images and quantification of the indicated cells in the wound‐healing migration assays. Scale bar, 100 µm. J) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. K) Protein expression of EMT‐associated proteins in HCC cells with MAP4K4 knockdown. L) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: Membranes were blocked with 5% non‐fat milk (Bio‐Rad) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: PEPT1 (1:1000, Huabio, #HA500444), MAP4K4 (1:1000, Cusabio, #CSB‐PA013439LA01HU), G3BP2 (1:1000, Proteintech, #16276‐1‐AP), phospho‐Threonine (1:1000, CST, #9386), E‐cadherin (1:1000, Proteintech, #20874‐1‐AP), N‐cadherin (1:1000, Proteintech, #22018‐1‐AP), vimentin (1:2500, Proteintech, #10366‐1‐AP), β‐catenin (1:1000, Huabio, #HA500444), and β‐actin (1:10 000, Proteintech, #66009‐1‐Ig).

    Techniques: Expressing, Over Expression, Knockdown, Stable Transfection, shRNA, Control, Binding Assay, Western Blot, Migration

    MAP4K4 directly binds to G3BP2 in HCC. A) Phosphorylated proteomics analysis identified G3BP2 in the binding protein pool. B,C) Endogenous interaction between MAP4K4 and G3BP2 was determined using co‐IP with anti‐MAP4K4 or anti‐G3BP2 antibodies in Huh7 and PLC/PRF/5 cells. D) Exogenous interaction between MAP4K4 and G3BP2 was determined using co‐IP with anti‐Flag or anti‐HA antibodies in HEK 293T cells co‐transfected with Flag‐G3BP2 and HA‐MAP4K4. E) Immunofluorescence staining showing colocalization of endogenous MAP4K4 (red) and G3BP2 (green) in Huh7 and PLC/PRF/5 cells. The nucleus is labeled by DAPI (blue). Scale bar: 20 µm. F) Immunofluorescence staining showing colocalization of exogenous HA‐MAP4K4 (red) and Flag‐G3BP2 (green) in HEK293T cells. The nucleus is labeled by DAPI (blue). Scale bar: 20 µm. G) Representative IHC images for MAP4K4 and G3BP2 in pulmonary metastatic lesions of nude mice developed by PEPT1‐knockdown or PEPT1‐overexpression HCC cells. Scale bar, 500 µm, 50 µm.

    Journal: Advanced Science

    Article Title: Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis

    doi: 10.1002/advs.202306671

    Figure Lengend Snippet: MAP4K4 directly binds to G3BP2 in HCC. A) Phosphorylated proteomics analysis identified G3BP2 in the binding protein pool. B,C) Endogenous interaction between MAP4K4 and G3BP2 was determined using co‐IP with anti‐MAP4K4 or anti‐G3BP2 antibodies in Huh7 and PLC/PRF/5 cells. D) Exogenous interaction between MAP4K4 and G3BP2 was determined using co‐IP with anti‐Flag or anti‐HA antibodies in HEK 293T cells co‐transfected with Flag‐G3BP2 and HA‐MAP4K4. E) Immunofluorescence staining showing colocalization of endogenous MAP4K4 (red) and G3BP2 (green) in Huh7 and PLC/PRF/5 cells. The nucleus is labeled by DAPI (blue). Scale bar: 20 µm. F) Immunofluorescence staining showing colocalization of exogenous HA‐MAP4K4 (red) and Flag‐G3BP2 (green) in HEK293T cells. The nucleus is labeled by DAPI (blue). Scale bar: 20 µm. G) Representative IHC images for MAP4K4 and G3BP2 in pulmonary metastatic lesions of nude mice developed by PEPT1‐knockdown or PEPT1‐overexpression HCC cells. Scale bar, 500 µm, 50 µm.

    Article Snippet: Membranes were blocked with 5% non‐fat milk (Bio‐Rad) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: PEPT1 (1:1000, Huabio, #HA500444), MAP4K4 (1:1000, Cusabio, #CSB‐PA013439LA01HU), G3BP2 (1:1000, Proteintech, #16276‐1‐AP), phospho‐Threonine (1:1000, CST, #9386), E‐cadherin (1:1000, Proteintech, #20874‐1‐AP), N‐cadherin (1:1000, Proteintech, #22018‐1‐AP), vimentin (1:2500, Proteintech, #10366‐1‐AP), β‐catenin (1:1000, Huabio, #HA500444), and β‐actin (1:10 000, Proteintech, #66009‐1‐Ig).

    Techniques: Binding Assay, Co-Immunoprecipitation Assay, Transfection, Immunofluorescence, Staining, Labeling, Knockdown, Over Expression

    G3BP2 was upregulated in HCC and influenced cell migration and invasion. A) G3BP2 protein levels in fresh HCC and adjacent nontumor tissues detected by Western blot ( n = 12). B) Representative IHC images of G3BP2 in HCC tissue ( n = 10) and corresponding normal tissue ( n = 10). Scale bar, 100 µm. C) The correlation between PEPT1 and G3BP2 (left), and MAP4K4 and G3BP2 (right) was analyzed based on the Western blot results. D) Representative images and quantification of the indicated cells in the wound‐healing migration assays. Scale bar, 100 µm. E) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. F) Protein expression of EMT‐associated proteins in HCC cells with G3BP2 knockdown. G) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Advanced Science

    Article Title: Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis

    doi: 10.1002/advs.202306671

    Figure Lengend Snippet: G3BP2 was upregulated in HCC and influenced cell migration and invasion. A) G3BP2 protein levels in fresh HCC and adjacent nontumor tissues detected by Western blot ( n = 12). B) Representative IHC images of G3BP2 in HCC tissue ( n = 10) and corresponding normal tissue ( n = 10). Scale bar, 100 µm. C) The correlation between PEPT1 and G3BP2 (left), and MAP4K4 and G3BP2 (right) was analyzed based on the Western blot results. D) Representative images and quantification of the indicated cells in the wound‐healing migration assays. Scale bar, 100 µm. E) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. F) Protein expression of EMT‐associated proteins in HCC cells with G3BP2 knockdown. G) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: Membranes were blocked with 5% non‐fat milk (Bio‐Rad) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: PEPT1 (1:1000, Huabio, #HA500444), MAP4K4 (1:1000, Cusabio, #CSB‐PA013439LA01HU), G3BP2 (1:1000, Proteintech, #16276‐1‐AP), phospho‐Threonine (1:1000, CST, #9386), E‐cadherin (1:1000, Proteintech, #20874‐1‐AP), N‐cadherin (1:1000, Proteintech, #22018‐1‐AP), vimentin (1:2500, Proteintech, #10366‐1‐AP), β‐catenin (1:1000, Huabio, #HA500444), and β‐actin (1:10 000, Proteintech, #66009‐1‐Ig).

    Techniques: Migration, Western Blot, Expressing, Knockdown

    PEPT1‐mediated dipeptides transport was essential for activating MAP4K4/G3BP2 axis. A) Endogenous interaction between PEPT1 and MAP4K4 was determined using co‐IP with anti‐MAP4K4 antibodies in Huh7 and PLC/PRF/5 cells. B) Metabolomics analysis identified dipeptides downregulated in Huh7 cells with stably PEPT1 knockdown. C) The uptake of Pro‐Gly in HCC cells with PEPT1 overexpressing and knockdown. D) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. E) Huh7 and PLC/PRF/5 cells were incubated with the indicated concentrations of Ile‐Ala or Gln‐Tyr for 24 hours, and the protein expression of MAP4K4, G3BP2, EMT‐associated proteins were detected by Western blot. Error bars indicate means ± SD. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Journal: Advanced Science

    Article Title: Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis

    doi: 10.1002/advs.202306671

    Figure Lengend Snippet: PEPT1‐mediated dipeptides transport was essential for activating MAP4K4/G3BP2 axis. A) Endogenous interaction between PEPT1 and MAP4K4 was determined using co‐IP with anti‐MAP4K4 antibodies in Huh7 and PLC/PRF/5 cells. B) Metabolomics analysis identified dipeptides downregulated in Huh7 cells with stably PEPT1 knockdown. C) The uptake of Pro‐Gly in HCC cells with PEPT1 overexpressing and knockdown. D) Representative images and quantification of the migration and invasion of the indicated cells in the Transwell assays. Scale bar, 250 µm. E) Huh7 and PLC/PRF/5 cells were incubated with the indicated concentrations of Ile‐Ala or Gln‐Tyr for 24 hours, and the protein expression of MAP4K4, G3BP2, EMT‐associated proteins were detected by Western blot. Error bars indicate means ± SD. * P < 0.05, ** P < 0.01, and *** P < 0.001.

    Article Snippet: Membranes were blocked with 5% non‐fat milk (Bio‐Rad) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: PEPT1 (1:1000, Huabio, #HA500444), MAP4K4 (1:1000, Cusabio, #CSB‐PA013439LA01HU), G3BP2 (1:1000, Proteintech, #16276‐1‐AP), phospho‐Threonine (1:1000, CST, #9386), E‐cadherin (1:1000, Proteintech, #20874‐1‐AP), N‐cadherin (1:1000, Proteintech, #22018‐1‐AP), vimentin (1:2500, Proteintech, #10366‐1‐AP), β‐catenin (1:1000, Huabio, #HA500444), and β‐actin (1:10 000, Proteintech, #66009‐1‐Ig).

    Techniques: Co-Immunoprecipitation Assay, Stable Transfection, Knockdown, Migration, Incubation, Expressing, Western Blot

    PEPT1/MAP4K4/G3BP2 signaling axis promoted HCC metastasis. A,C) Western blot analysis showed that the knockdown efficacy of MAP4K4 or G3BP2 in Bel7405 and HCCLM3 cells with PEPT1 overexpressing. B,D) Transwell assays revealed that migration and invasion ability was abrogated in Bel7405 and HCCLM3 cells with MAP4K4 or G3BP2 knockdown compared with the control group. Scale bar, 250 µm. E,G) Western blot analysis showed that the overexpression efficacy of G3BP2 (or PEPT1) in Huh7 cells with MAP4K4 (or G3BP2) knockdown. F,H) Inhibited migration and invasion of Huh7 cells with MAP4K4 (or G3BP2) knocked down was rescued by the overexpression of G3BP2 (or PEPT1). Left, representative images of Transwell assays, scale bar, 250 µm. Right, statistical analysis of Transwell assays. I) A schematic diagram of the PEPT1/MAP4K4/G3BP2 regulatory signaling axis that facilitates HCC metastasis.

    Journal: Advanced Science

    Article Title: Peptide Transporter 1‐Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis

    doi: 10.1002/advs.202306671

    Figure Lengend Snippet: PEPT1/MAP4K4/G3BP2 signaling axis promoted HCC metastasis. A,C) Western blot analysis showed that the knockdown efficacy of MAP4K4 or G3BP2 in Bel7405 and HCCLM3 cells with PEPT1 overexpressing. B,D) Transwell assays revealed that migration and invasion ability was abrogated in Bel7405 and HCCLM3 cells with MAP4K4 or G3BP2 knockdown compared with the control group. Scale bar, 250 µm. E,G) Western blot analysis showed that the overexpression efficacy of G3BP2 (or PEPT1) in Huh7 cells with MAP4K4 (or G3BP2) knockdown. F,H) Inhibited migration and invasion of Huh7 cells with MAP4K4 (or G3BP2) knocked down was rescued by the overexpression of G3BP2 (or PEPT1). Left, representative images of Transwell assays, scale bar, 250 µm. Right, statistical analysis of Transwell assays. I) A schematic diagram of the PEPT1/MAP4K4/G3BP2 regulatory signaling axis that facilitates HCC metastasis.

    Article Snippet: Membranes were blocked with 5% non‐fat milk (Bio‐Rad) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: PEPT1 (1:1000, Huabio, #HA500444), MAP4K4 (1:1000, Cusabio, #CSB‐PA013439LA01HU), G3BP2 (1:1000, Proteintech, #16276‐1‐AP), phospho‐Threonine (1:1000, CST, #9386), E‐cadherin (1:1000, Proteintech, #20874‐1‐AP), N‐cadherin (1:1000, Proteintech, #22018‐1‐AP), vimentin (1:2500, Proteintech, #10366‐1‐AP), β‐catenin (1:1000, Huabio, #HA500444), and β‐actin (1:10 000, Proteintech, #66009‐1‐Ig).

    Techniques: Western Blot, Knockdown, Migration, Control, Over Expression